Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 32,639,000 | 24,890,000 | 11,202,000 | 9,702,000 | 8,385,385 |
| Cost of Goods | 4,006,000 | 3,788,000 | 2,859,000 | 2,471,000 | 2,124,410 |
| Gross Profit | 28,633,000 | 21,102,000 | 8,343,000 | 7,231,000 | 6,260,975 |
| Operating Expenses | 6,440,000 | 5,837,000 | 3,819,000 | 3,221,000 | 2,471,544 |
| Operating Income | 22,193,000 | 15,265,000 | 4,524,000 | 4,010,000 | 3,789,841 |
| Interest Expense | 688,000 | 412,000 | 307,000 | 361,000 | 205,418 |
| Other Income | 154,000 | 3,000 | -9,000 | -37,000 | 66,581 |
| Pre-tax Income | 21,659,000 | 14,856,000 | 4,208,000 | 3,612,000 | 3,651,004 |
| Income Tax | 3,553,000 | 2,797,000 | 1,151,000 | 1,038,000 | 861,945 |
| Net Income Continuous | 18,106,000 | 12,059,000 | 3,057,000 | 2,574,000 | 2,789,059 |
| Minority Interests | -2,000 | -42,000 | -18,000 | -18,000 | -14,578 |
| Net Income | $18,108,000 | $12,101,000 | $3,075,000 | $2,592,000 | $2,803,637 |
| EPS Basic Total Ops | 12.37 | 7.95 | 2.01 | 1.71 | 1.81 |
| EPS Basic Continuous Ops | 12.37 | 7.92 | 2.00 | 1.70 | 1.80 |
| EPS Diluted Total Ops | 11.91 | 7.35 | 1.81 | 1.64 | 1.77 |
| EPS Diluted Continuous Ops | 11.90 | 7.32 | 1.80 | 1.63 | 1.77 |
| EBITDA(a) | $23,291,000 | $16,315,000 | $4,869,000 | $4,288,000 | $4,092,073 |